Valeant Bumps Cash Portion of Allergan Offer by 21%

May 28, 2014 AT 6:35 AM
May 28 (Bloomberg) -- Bloomberg’s Tom Keene and Cristina Alesci report that Valeant Pharmaceuticals has raised its unsolicited offer for Allergan by boosting the cash portion of the bid by 21 percent. They speak on Bloomberg Television’s “Bloomberg Surveillance.”